White Papers

  1. The Regulatory Evolution And Data Revolution In Medical Device Development 7/4/2022

    The Life Sciences and Healthcare industries are among the most heavily regulated industries in the world. This paper looks at the current, dynamic regulatory landscape within the medical devices sector and some of the current and future changes medical device organizations will need to adhere to. The in-vitro diagnostics (IVD) sector is also going through regulatory change - a topic that is out of scope for this paper.

  2. Hassle-Free Imaging In Clinical Trials 6/14/2022

    In this paper, writers ask readers to consider how far the field of imaging has transpired in recent times, as well as explore the latest innovations, and contemplate what possibilities lie ahead.

  3. Modernizing Direct-To-Patient Clinical Trials 5/20/2022

    This paper provides an overview of factors underlying the rapid and ongoing modernization of clinical trials and provides a short discussion of DtP trials and demonstrates how they can solve some of the difficulties you may be facing today.

  4. Trends And Challenges In Rare Disease Clinical Development 3/2/2022

    Looking back over the past few years and projecting forward, one of the strongest trends in the pharmaceutical industry centers on rare diseases. Learn some of the major themes, concerns, and challenges surrounding rare disease trials. 

  5. DCTs: What Are They And What Are The Direct Impacts To DMs? 1/21/2022

    In 2020, the need for alternative approaches to clinical trial execution and data capture became a reality overnight. The concept of implementing components of decentralization within a clinical trial became one of ‘here and now,’ versus a concept of the future. 

  6. Decentralized Clinical Trials: The Future Of Clinical Research Is Here 12/20/2021

    This white paper provides an introduction to DCTs and summarizes the state of the industry from the perspective of different stakeholders, including the pharmaceutical and medical device industries, regulators across the world, and patients.

  7. Optimize RTSM For Efficient Clinical Trial Implementation 11/22/2021

    One of the most challenging aspects of conducting an RCT is the timely system setup. Unearth the benefits that an optimized RTSM system can offer for clinical trial sponsors.

  8. Advancing DCTs Through A Unified Approach To eCOA And DHTs 7/6/2021

    Digital health technologies and assessments of patient-reported outcomes are on the rise. Read how uniting the two can better inform how patients experience their disease and respond to treatment.

  9. Transform Your Drug Safety Data And Adjudication Processes With Technology 7/6/2021

    Many may not know that cloud platforms can help streamline clinical endpoint adjudication. Read below to see how these play a role in cutting costs, improving data quality, smoothing regulatory approval, and speeding time to market.

  10. Developing A Mobile Sensor Strategy Journey For Better Study Outcomes 4/15/2021

    With the growth of digital health technologies and an increasingly large selection of possible devices, this white paper highlights considerations as sponsors and CROs develop their DHT strategy.